Dataset: Discovery: Considering PubMed #41177462 and PubMed #41231952, Spermidine-modified extracellular vesicles can mitigate ALS-related C9orf72 RAN translation by modulating the MARK2-eIF2α stress-sensing axis. - PathMap Experiment #000120

Interactive Data Viewer: Read, View, and Print from Day 1 Use our fully interactive viewer to view, read, and print this research data right from Day 1: https://pathmap.org/viewer.php?id=120 Artificial General Intelligence LLC Claim Evaluated: Discovery: Considering PubMed #41177462 and PubMed #41231952, Spermidine-modified extracellular vesicles can mitigate ALS-related C9orf72 RAN translation by modulating the MARK2-eIF2α stress-sensing axis. This dataset contains the raw JSON execution trace, verified verbatim quotes, and MeSH-aligned logic gates generated by PathMap Studio's Veridical Enforcement engine. 🔍 Novel & Overlooked Insights MARK2-eIF2α signaling is a primary driver of noncanonical RAN translation in C9orf72 expansions (ID: 41231952). Spermidine and its derivatives function as translation modifiers capable of enhancing cell health through autophagy and eIF5a hypusination (ID: 41430470, 22932872). The use of ginseng-derived extracellular vesicles modified by spermidine provides a blueprint for targeted delivery to olfactory receptor neurons (ID: 41177462). Cardiac autonomic dysfunction is an underrecognized, significant contributor to ALS burden, highlighting the multisystem nature of the disease (ID: 42441693). Metabolomic profiling suggests that TJ-68 treatment in ALS modulates metabolites linked to muscle cramp severity, such as serotonin and acetylcarnitine (ID: 42461445). 🧪 Extracted Custom Datapoints 📊 Suggested Experiments Determine if S-GEVs@siRNA targeting MARK2 in C9orf72 patient-derived neurons reduces DPR formation. Evaluate the impact of spermidine-supplemented nanoparticle treatment on eIF2alpha phosphorylation status in C9orf72 models. 📊 Suggested Studies In vivo assessment of S-GEVs@siRNA in SOD1 and C9orf72 mouse models of ALS to determine if cognitive and motor decline is mitigated. Comparative longitudinal study of cardiac autonomic indices and NfL levels in patients treated with experimental ISR-inhibiting pharmacotherapies. 📊 Swansons Literature Based Discovery Candidates Intranasal spermidine-nanoparticle delivery can inhibit the MARK2-eIF2α stress-sensing cascade to alleviate RAN translation. Spermidine-modified extracellular vesicles as a nasal-to-brain delivery system (ID: 41177462). MARK2 kinase as a therapeutic target for suppressing RAN translation (ID: 41231952). Integrated Stress Response (ISR) and eIF2α signaling. The ISR, driven by MARK2, promotes pathological RAN translation; since spermidine has been shown to modulate cellular stress responses and can be used to target nanocarriers to the brain, it provides a delivery vehicle for suppressing this kinase. 📊 Contradictions Between Evidences There is no direct contradiction, but there is a clear tension between studies focusing on the activation of the ISR to promote translation (ID: 29222490) and studies focusing on inhibiting the ISR as a therapeutic strategy (ID: 30617154). 📊 Repurposed Solutions The use of spermidine-modified extracellular vesicles (originally for RBI treatment) could be repurposed for delivering siRNA targeting MARK2 in ALS-FTD patients to inhibit DPR production. Tags Attractor Table Extracted Keywords & Entities C9orf72 Protein, _gates_from_c9orf72_protein, EIF2A, _gates_to_eif2a, _gates_from_eif2a, Nanoparticles, _gates_to_nanoparticles Run Your Own Analysis PathMap is a patent-pending universal AI workbench designed to eliminate LLM hallucinations in medical research. Generate your own autonomous discovery reports at PathMap.org.